|
The TeamThe executive leadership team at Vapogenix brings a wealth of experience from medical and pharmaceutical industries, positioning them to make valuable contributions to the company's success. Collectively, their knowledge of these sectors is extensive, providing a solid foundation for strategic decision-making within Vapogenix.
Team members have held leadership positions in both large and small pharmaceutical companies, contributing to innovation and the development of groundbreaking pharmaceutical products. Members have successfully founded or managed several large medical and pharmaceutical companies which successfully commercialized their products and lead to high return exits with valuations. Their background in research and development is a significant asset. This strategic acumen will help to guide Vapogenix in achieving long-term objectives and maintaining a competitive edge in the pharmaceutical industry. Furthermore, their experience extends to advisory and board roles in various healthcare and financial technology companies, showcasing their ability to offer well-rounded guidance and establish valuable connections within the industry. Importantly, the team has a proven track record of success in their previous roles, which underscores their capacity to lead effectively, execute strategies, and deliver results for Vapogenix. |
Lester Zuckerman, MD
|
Dr. Lester Zuckerman, is a nationally recognized leader in pain management. He completed an Anesthesiology Residency and Interventional Pain Fellowship at the University of Pennsylvania in 1995. He then joined the staff at the hospital of The University of Pennsylvania as an instructor in Anesthesiology and Pain management as part of its residency and fellowship programs.
In 1998 Dr. Zuckerman co-founded National Spine & Pain Centers (NSPC). Serving as a member of NSPC’s Board of Directors, and the practice’s Chief Medical Officer, the company grew to become the nation’s largest interventional pain management practice. NSPC delivered services in 8 states with nearly 200 clinicians seeing nearly 1M patients annually. Through two successful PE co-investments and exits the company achieved an EV of over 400M. He has also held posts as the Director for The Center for Pain Management at Englewood Hospital (New Jersey) and the Director of Pain Management Services for the Veteran’s Administration Hospital (Philadelphia, PA). A seasoned pain management specialist with 20 years of experience, his contribution the specialty of Pain Management and approach to patient care have regularly merited peer recognition. An advocate for continuing education, Dr. Zuckerman dedicates considerable time to exploring advances in pain management techniques and emerging therapies. He has been published in top-tier professional journals and has lectured to peers and the public on the diagnosis and treatment of pain syndromes. |
Marc Loev, MD
|
Dr. Marc Loev is a nationally recognized leader in pain management. He completed an Anesthesiology Residency and Interventional Pain Fellowship at the University of Pennsylvania in 1997. He then joined the staff at the hospital of The University of Pennsylvania as an instructor in Anesthesiology and Pain management as part of its residency and fellowship programs.
In 1998 Dr. Loev co-founded National Spine & Pain Centers (NSPC). Serving as NSPC’s CEO and Vice Chair of NSPC’s Board of Directors the company grew to become the nation’s largest interventional pain management practice. NSPC delivered services in 8 states with nearly 200 clinicians seeing nearly 1M patients annually. Through two successful PE co-investments and exits the company achieved an EV of over 400M. |
Heather Giles, PhD
|
Dr. Heather Giles Dr. is a results-oriented senior executive with extensive international experience in large and small pharmaceutical companies. She has a proven record of strategic leadership and dynamic management of drug discovery and development from target validation, through clinical studies to final regulatory submission. He/She has recent experience of establishing a European organization to launch a new drug. Dr. Giles is an internationally recognized pharmacologist and an adjunct professor at the University of Houston, Texas.
Key Skills:
|
Ajay Rege, PhD
|
Dr. Rege has over 25 years of experience in pharmaceutical/biotech operations. He has a deep understanding of the challenges and opportunities in bringing new products to market.
|